Vergleich

Lamin B2

ArtNr 20-512-300061
Hersteller GENWAY
Menge 0.1 mg
Kategorie
Typ Antibody
Clon LN43
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-CDEBA7
Similar products 20-512-300061
Lieferbar
Genway ID:
GWB-CDEBA7
Subclass:
IgG1
Clone:
LN43
Specificity:
LN43 reacts with an epitope located in the Cterminal part of lamin B2. LN43 is suitable for immunohistochemistry on frozen sections. immunoblotting and flow cytometry. Optimal antibody dilution should be determined by titration; recommended range is 1:100 ? 1:200 for flow cytometry. and for immunohistochemistry with avidin-biotinylated horseradish peroxidase complex (ABC) as detection reagent. and 1:100 ? 1:1000 for immunoblotting applications. Product
Note:
Each vial contains 100 ?l 1 mg/ml purified antibody in PBS containing 0. 09% sodium azide. Nuclear lamins form a network of intermediate-type filaments at the nucleoplasmic site of the nuclear membrane. Two main subtypes of nuclear lamins can be distinguished. i. e. A-type lamins and B-type lamins. The A-type lamins comprise a set of three proteins arising from the same gene by alternative splicing. i. e. lamin A. lamin C and lamin Adel 10. while the B-type lamins include two proteins arising from two distinct genes. ie lamin B1 and lamin B2.
Function:
Lamins are components of the nuclear lamina a fibrous layer on the nucleoplasmic side of the inner nuclear membrane which is thought to provide a framework for the nuclear envelope and may also interact with chromatin.
Subunit:
Interacts with TMEM43 (By similarity).
Subcellular Location:
Nucleus inner membrane; Lipid-anchor; Nucleoplasmic side.
Ptm:
B-type lamins undergo a series of modifications such as farnesylation and phosphorylation. Increased phosphorylation of the lamins occurs before envelope disintegration and probably plays a role in regulating lamin associations.
Disease:
Defects in LMNB2 are a cause of partial acquired lipodystrophy (APL) [MIM:608709]; also called Barraquer-Simons syndrome. APL is a rare childhood disease characterized by loss of subcutaneous fat from the face and trunk. Fat deposition on the pelvic girdle and lower limbs is normal or excessive. Most frequently onset between 5 and 15 years of age. Most affected subjects are females and some show no other abnormality but many develop glomerulonephritis diabetes mellitus hyperlipidaemia and complement deficiency. Mental retardation in some cases. APL is a sporadic disorder of unknown aetiology.
Miscellaneous:
The structural integrity of the lamina is strictly controlled by the cell cycle as seen by the disintegration and formation of the nuclear envelope in prophase and telophase respectively.
Similarity:
Belongs to the intermediate filament family. 1. Bridger. J. M. Kill. I. R. O\' Farrell. M. and Hutchison. C. J. (1993). Internal lamin structures within G1 nuclei of human dermal fibroblasts. J Cell Sci 104. 297-306. 2. Jenkins. H. Hö lman. T. Lyon. C. Lane. B. Stick. R. and Hutchison. C. J. (1993). Nuclei that lack a lamina accumulate karyophilic proteins and assemble a nuclear matrix. J Cell Sci 106. 275-285. 3. Hozak. P. Sasseville. A. M. Raymond. Y. and Cook. P. R. (1995). Lamin proteins form an internal nucleoskeleton as well as a peripheral lamina in human cells. J Cell Sci 108. 635-44. 5. Machiels. B. M. Zorenc. A. H. Endert. J. M. Kuijpers. H. J. van Eys. G. J. Ramaekers. F. C. and Broers. J. L. (1996). An alternative splicing product of the lamin A/C gene lacks exon 10. J Biol Chem 271. 9249-53. 6. Machiels. B. M. Ramaekers. F. C. Kuijpers. H. J. Groenewoud. J. S. Oosterhuis. J. W. and Looijenga. L. H. (1997). Nuclear lamin expression in normal testis and testicular germ cell tumours of adolescents and adults. J Pathol 182. 197-204. 7. Jansen. M. P. Machiels. B. M. Hopman. A. H. Broers. J. L. Bot. F. J. Arends. J. W. Ramaekers. F. C. and Schouten. H. C. (1997). Comparison of A and B-type lamin expression in reactive lymph nodes and nodular sclerosing Hodgkin\' s disease. Histopathology 31. 304-12.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 0.1 mg
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen